Article Versions Notes

Herbener VJ, Burster T, Goreth A, Pruss M, von Bandemer H, Baisch T, Fitzel R, Siegelin MD, Karpel-Massler G, Debatin K-M, et al. Considering the Experimental Use of Temozolomide in Glioblastoma Research. Biomedicines. 2020; 8(6):151. https://doi.org/10.3390/biomedicines8060151

Herbener, Verena J., Timo Burster, Alicia Goreth, Maximilian Pruss, Hélène von Bandemer, Tim Baisch, Rahel Fitzel, Markus D. Siegelin, Georg Karpel-Massler, Klaus-Michael Debatin, and et al. 2020. "Considering the Experimental Use of Temozolomide in Glioblastoma Research" Biomedicines 8, no. 6: 151. https://doi.org/10.3390/biomedicines8060151

Herbener, V. J., Burster, T., Goreth, A., Pruss, M., von Bandemer, H., Baisch, T., Fitzel, R., Siegelin, M. D., Karpel-Massler, G., Debatin, K.-M., Westhoff, M.-A., & Strobel, H. (2020). Considering the Experimental Use of Temozolomide in Glioblastoma Research. Biomedicines, 8(6), 151. https://doi.org/10.3390/biomedicines8060151